BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 11002243)

  • 21. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
    Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
    World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration of HCV-RNA and HBV-DNA in the serum of HBsAg negative patients with hepatocellular carcinoma.
    Enríquez J; Fuchs K; Martínez Cerezo FJ; Seminago R; Madoz P; Torras J; Roggendorf M
    Eur J Epidemiol; 1994 Apr; 10(2):189-94. PubMed ID: 7813697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State of HBV DNA in HBsAg-negative, anti-HCV-positive hepatocellular carcinoma: existence of HBV DNA possibly as nonintegrated form with analysis by Alu-HBV DNA PCR and conventional HBV PCR.
    Kawai S; Yokosuka O; Imazeki F; Maru Y; Saisho H
    J Med Virol; 2001 Aug; 64(4):410-8. PubMed ID: 11468724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus.
    Tamori A; Nishiguchi S; Kubo S; Koh N; Moriyama Y; Fujimoto S; Takeda T; Shiomi S; Hirohashi K; Kinoshita H; Otani S; Kuroki T
    Hepatology; 1999 May; 29(5):1429-34. PubMed ID: 10216126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
    Tamori A; Hayashi T; Shinzaki M; Kobayashi S; Iwai S; Enomoto M; Morikawa H; Sakaguchi H; Shiomi S; Takemura S; Kubo S; Kawada N
    J Med Virol; 2009 Jun; 81(6):1009-14. PubMed ID: 19382258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
    Kim DG
    Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of hepatitis B virus x transcripts in human hepatocellular carcinoma tissues.
    Kobayashi S; Saigoh Ki; Urashima T; Asano T; Isono K
    J Surg Res; 1997 Dec; 73(2):97-100. PubMed ID: 9441800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study.
    Ikeda K; Kobayashi M; Someya T; Saitoh S; Hosaka T; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H
    J Viral Hepat; 2009 Jun; 16(6):437-43. PubMed ID: 19226331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea.
    Park BC; Han BH; Ahn SY; Lee SW; Lee DH; Lee YN; Seo JH; Kim KW
    J Viral Hepat; 1995; 2(4):195-202. PubMed ID: 7489347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
    Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
    Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic mutations with amino acid substitutions of circulating hepatitis B virus found in non-B, non-C patients with hepatocellular carcinoma.
    Nakamoto N; Saito H; Ebinuma H; Tada S; Saito Y; Kurita S; Kitamura K; Ishii H
    Intern Med; 2003 Apr; 42(4):322-30. PubMed ID: 12729320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.
    Saitta C; Tripodi G; Barbera A; Bertuccio A; Smedile A; Ciancio A; Raffa G; Sangiovanni A; Navarra G; Raimondo G; Pollicino T
    Liver Int; 2015 Oct; 35(10):2311-7. PubMed ID: 25677098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
    Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil.
    Branco F; Mattos AA; Coral GP; Vanderborght B; Santos DE; França P; Alexandre C
    Arq Gastroenterol; 2007; 44(1):58-63. PubMed ID: 17639185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
    Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
    J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
    Tanaka T; Inoue K; Hayashi Y; Abe A; Tsukiyama-Kohara K; Nuriya H; Aoki Y; Kawaguchi R; Kubota K; Yoshiba M; Koike M; Tanaka S; Kohara M
    J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.
    Bréchot C; Jaffredo F; Lagorce D; Gerken G; Meyer zum Büschenfelde K; Papakonstontinou A; Hadziyannis S; Romeo R; Colombo M; Rodes J; Bruix J; Williams R; Naoumov N
    J Hepatol; 1998 Aug; 29(2):173-83. PubMed ID: 9722197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.